Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.67 |
| ▸ | S100A4 | P26447 | 1/20 | 0.67 |
| ▸ | MTOR | P42345 | 1/20 | 0.67 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9430679 | 1.00 | ALDH1A1 (0.67) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL11401607 | 0.86 | TLR9 (0.70) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL11830665 | 0.84 | KMT2A (0.60) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL11830661 | 0.84 | KMT2A (0.60) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL9811481 | 0.81 | TLR9 (0.61) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL9811484 | 0.81 | TLR9 (0.61) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL11842686 | 0.81 | KEAP1 (0.58) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL20774376 | 0.80 | ALDH1A1 (0.68) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL20774334 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TDP1MAPTHPGDCYP1A2 | |
| SCHEMBL20774374 | 0.80 | ALDH1A1 (0.68) | ALDH1A1TDP1MAPTHPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098354-A1 | LITHIUM BATTERY AQUEOUS BINDER AND PREPARATION METHOD THEREFOR | 广州天赐高新材料股份有限公司 | 2026-05-15 | — | — | WO | claimed |
| CN-122011977-A | Aqueous binder for lithium battery and preparation method thereof | 广州天赐高新材料股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-2025082489-A1 | ADDITIVE FOR NEGATIVE ELECTRODE OF LITHIUM-ION BATTERY | 广州天赐高新材料股份有限公司 | 2025-04-24 | — | — | WO | claimed |
| US-20250059074-A1 | ANTIMICROBIAL SYSTEM AND METHOD | KEMIRA OYJ (FI) | 2025-02-20 | — | — | US | claimed |
| US-20240383784-A1 | ANTIMICROBIAL SYSTEM AND METHOD | KEMIRA OYJ (FI) | 2024-11-21 | — | — | US | claimed |
| EP-4447666-A1 | ANTIMICROBIAL SYSTEM AND METHOD | Kemira OYJ (FI) | 2024-10-23 | — | — | EP | claimed |
| EP-4447685-A1 | ANTIMICROBIAL SYSTEM AND METHOD | Kemira OYJ (FI) | 2024-10-23 | — | — | EP | claimed |
| CN-117417474-A | Negative electrode additive for lithium battery | 广州天赐高新材料股份有限公司 | 2024-01-19 | — | — | CN | claimed |
| WO-2023118172-A1 | ANTIMICROBIAL SYSTEM AND METHOD | KEMIRA OYJ (FI) | 2023-06-29 | — | — | WO | claimed |
| WO-2023118170-A1 | ANTIMICROBIAL SYSTEM AND METHOD | KEMIRA OYJ (FI) | 2023-06-29 | — | — | WO | claimed |
| US-11643782-B2 | Method for controlling growth of microorganisms and/or biofilms in an industrial process | KEMIRA OYJ (FI) | 2023-05-09 | — | — | US | claimed |
| CN-116014227-A | Composite material and preparation method thereof, composite gel electrolyte and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2023-04-25 | — | — | CN | claimed |
| EP-4162084-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | Kemira OYJ (FI) | 2023-04-12 | — | — | EP | claimed |
| EP-4139523-A1 | A METHOD OF CONTROLLING ENZYMATIC ACTIVITIES AND TOOLS RELATED THERETO | Kemira OYJ (FI) | 2023-03-01 | — | — | EP | claimed |
| US-20220142160-A1 | METHOD OF INHIBITING OR REDUCING BIOFILM IN A PETROLEUM PRODUCTION PROCESS | STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED (GB) | 2022-05-12 | — | — | US | claimed |
| US-20220056641-A2 | Method for controlling growth of microorganisms and/or biofilms in an industrial process | KEMIRA OYJ (FI) | 2022-02-24 | — | — | US | claimed |
| EP-3914081-A1 | METHOD OF INHIBITING OR REDUCING BIOFILM IN A PETROLEUM PRODUCTION PROCESS | Kemira Oyj (FI) | 2021-12-01 | — | — | EP | claimed |
| EP-3676445-A1 | METHOD FOR CONTROLLING GROWTH OF MICROORGANISMS AND/OR BIOFILMS IN AN INDUSTRIAL PROCESS | Kemira Oyj (FI) | 2020-07-08 | — | — | EP | claimed |
| US-20200199818-A1 | Method for controlling growth of microorganisms and/or biofilms in an industrial process | KEMIRA OYJ (FI) | 2020-06-25 | — | — | US | claimed |
| WO-2019042985-A1 | METHOD FOR CONTROLLING GROWTH OF MICROORGANISMS AND/OR BIOFILMS IN AN INDUSTRIAL PROCESS | KEMIRA OYJ (FI) | 2019-03-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220142160-A1 | METHOD OF INHIBITING OR REDUCING BIOFILM IN A PETROLEUM PRODUCTION PROCESS | BLVRB, BPHL, PGLS | ALDH1A1 1352/4885TDP1 1351/4885MAPT 3733/4885 |
| US-20250059074-A1 | ANTIMICROBIAL SYSTEM AND METHOD | HAO2, APEH, CHCHD6 | ALDH1A1 577/4885TDP1 4387/4885MAPT 4815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.